OOIR: Observatory of International Research

Papers

(The H4-Index of World Journal of Gastroenterology is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted	283
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	269
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China	221
Liquid biopsy for gastric cancer: Techniques, applications, and future directions	180
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	159
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	134
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	119
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	116
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	101
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	100
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	98
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	94
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	94
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	85
Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer	84
Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer	80
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	79
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	79
Intestinal flora was associated with occurrence risk of chronic non-communicable diseases	78
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	73
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	73
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	69
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome	67
Prognostic impact and reasons for variability by tumor location in gastric cancer	66
Modern drug discovery for inflammatory bowel disease: The role of computational methods	65

Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	63
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease	63
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	61
Management of Flood syndrome: What can we do better?	59
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	57
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	56
Abdominal cocoon in children: A case report and review of literature	56
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer	56
Examining dietary interventions in Crohn’s disease	54
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	54
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study	53
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism	52
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells	52
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	52
Prostaglandin F_2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F_2α-dependent and F_2α-independent mechanism	51
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management	50
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	49
Systemic treatment for metastatic colorectal cancer	49
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity	49
New objective scoring system to clinically assess fecal incontinence	48
Factors other than fibrosis that increase measured shear wave velocity	48
Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy	47
Nonlinear association between estimated plasma volume status and acute kidney injury in acute pancreatitis patients	47